Browse abstracts for all scientific posters that have been presented at the AAPP Annual Meeting.
Use the search box to quickly locate an abstract by any data in the column, including "PGY2"! The site search provides full-text search of all abstracts that have been presented at the AAPP Annual Meeting over the years.
Browse: 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025
Title | Type | Presenter | Session | ||
---|---|---|---|---|---|
![]() | A 6-MONTH PLACEBO-CONTROLLED STUDY OF VENLAFAXINE XR IN THE TREATMENT OF POSTTRAUMATIC STRESS DISORDER | Encore Presentation | |||
![]() | A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents | Work in Progress | |||
![]() | A Naturalistic, Retrospective Evaluation of Aripiprazole Use in Child and Adolescent Psychiatric Inpatients | Work in Progress | |||
![]() | A Psychoeducation Program that Reduces Metabolic Syndrome Risk Factors in the Severe and Persistently Mentally Ill | Original Research | |||
![]() | A retrospective evaluation of metabolic indices in patients who switched atypical antipsychotic agents | Work in Progress | |||
![]() | Abuse of psychotropic medication in the correctional setting: identification, assessment and harm reduction through education & formulary changes | Best Practices | |||
![]() | ACUTE WEIGHT GAIN WITH COMBINATION DIVALPROEX SODIUM AND OLANZAPINE IN CHILDREN AND ADOLESCENT INPATIENTS AT A UNIVERSITY HOSPITAL | Encore Presentation | |||
![]() | ADAMANTANE DERIVATIVE (MEMANTINE): PHARMACOKINETICS IN HEALTHY AND RENALLY IMPAIRED SUBJECTS | Original Research | |||
![]() | Adherence to American Psychiatric Association Practice Guidelines for the Treatment of Patients with Severe Acute Mania | Work in Progress | |||
![]() | Adjunct Divalproex or Lithium to Clozapine in Treatment-Resistant Schizophrenia | Encore Presentation | |||
![]() | ADVERSE EVENTS DURING ANTIPSYCHOTIC CLINICAL TRIALS OF ELDERLY PATIENTS WITH DEMENTIA | Encore Presentation | |||
![]() | An assessment of safety, preference, effectiveness, quality of life, and tolerability (SPEQT) in patients with epilepsy switched from immediate-release to extended-release carbamazepine capsules | Encore Presentation | |||
![]() | Analog Classroom Study of Amphetamine Extended Release and Atomoxetine in Youth with ADHD | Encore Presentation | |||
![]() | Analysis of the Efficacy of Venlafaxine vs Placebo in A Subgroup of Patients With Moderate or Severe Major Depression | Encore Presentation | |||
![]() | ANTIDEPRESSANT MEDICATION MANAGEMENT IN DEPRESSION PATIENTS: A ROLE FOR CLINICAL PHARMACISTS | Work in Progress | |||
![]() | Antidepressants and risk of falls | Original Research | |||
![]() | Antipsychotic Polypharmacy: Pharmacoepidemiology and Potential Predictors of Utilization | Original Research | |||
![]() | Antipsychotics and Side Effect Burden: A Prospective Study Comparing Antipsychotic Monotherapy Versus Combination Therapy | Work in Progress | |||
![]() | ARIPIPRAZOLE BIOEQUIVALENCE: ORALLY DISINTEGRATING TABLET COMPARED TO TABLET FORMULATION | Encore Presentation | |||
![]() | Aripiprazole induced seizure in an adolescent | Encore Presentation | |||
![]() | Assessment of Patient Satisfaction with Sustained-release Antidepressant Use in a Family Practice Setting: Pilot Study of Antidepressant Survey | Work in Progress | |||
![]() | ASSOCIATION BETWEEN MEDICATION CHANGES AND FALLS IN GERIATRIC PSYCHIATRY PATIENTS | Work in Progress | |||
![]() | Association of Anxiety Symptoms with Treatment Outcomes Among Outpatients With Major Depression | Original Research | |||
![]() | ATOMOXETINE EFFICACY FOR SEVERE HYPERACTIVE AND INATTENTIVE ADHD SYMPTOMS | Encore Presentation | |||
![]() | ATOMOXETINE’S EFFICACY OVER TIME IN CHILDREN AND ADOLESCENTS WITH ADHD | Encore Presentation | |||
![]() | Atypical Antipsychotic Agents & Risk Factors for Diabetes Mellitus: Comparing Schizophrenic & Bipolar Disorder Patients | Encore Presentation | |||
![]() | CARDIOVASCULAR EFFECTS OF EXTENDED-RELEASE MIXED AMPHETAMINE SALTS IN CHILDREN WITH ADHD | Encore Presentation | |||
![]() | CARDIOVASCULAR EFFECTS OF MIXED AMPHETAMINE SALTS XR IN ADULT ADHD | Encore Presentation | |||
![]() | Centralized Pharmaceutical Care Consultations in a Regional State Psychiatric Facility | Best Practices | |||
![]() | Clinical and Economic Outcomes Associated with the Use of Long Acting Risperidone Injection in a Texas Community Mental Health Clinic | Work in Progress | |||
![]() | CLINICAL RELEVANCE OF DEPRESSIVE SYMPTOM IMPROVEMENT IN BIPOLAR DEPRESSED PATIENTS TREATED WITH OLANZAPINE-FLUOXETINE COMBINATION | Encore Presentation | |||
![]() | CONCERNS OF MENTAL HEALTH CONSERVATORSHIP ATTORNEYS REGARDING PSYCHOTROPIC MEDICATION USE -- IMPLICATIONS FOR PRACTITIONERS | Best Practices | |||
![]() | Continuity of Antipsychotic Pharmacotherapy Among Medicaid Recipients | Original Research | |||
![]() | Delirium in Long-Term Care Residents Predicted by an Anticholinergic Drug Rating Scale and Not Serum Anticholinergic Activity | Original Research | |||
![]() | Development and Implementation of Computerized Staff Training Modules to Teach Psychopharmacology | Original Research | |||
![]() | Development of Aligorithms for Three Main Axis I Disorders ( Schizophrenia, Bipolar Disorder and Major Depression) in a Community Based Mental Health Facility | Best Practices | |||
![]() | Development of Doctor of Pharmacy Industry Advanced Practice Experience | Best Practices | |||
![]() | Double-Blind, Placebo-Controlled Study of Quetiapine in Bipolar Depression | Encore Presentation | |||
![]() | DULOXETINE AT DOSES OF 60 MG QD AND 60 MG BID IS FFECTIVE IN TREATMENT OF DIABETIC NEUROPATHIC PAIN (DNP) | Encore Presentation | |||
![]() | DULOXETINE VS. PLACEBO IN THE TREATMENT OF ELDERLY PATIENTS WITH MDD | Encore Presentation | |||
![]() | Effect of Food on the Bioavailability of Galantamine Extended-Release (ER) Capsule and Pharmacokinetic Comparison of Galantamine ER with Galantamine Immediate-Release (IR) Tablet | Original Research | |||
![]() | EFFECT OF MEMANTINE ON BEHAVIORAL OUTCOMES IN MILD TO SEVERE ALZHEIMER’S DISEASE | Original Research | |||
![]() | EFFICACY AND TOLERABILITY OF DULOXETINE: COMPARISON OF 30 MG QD AND 60 MG QD STARTING DOSES | Encore Presentation | |||
![]() | EFFICACY OF ARIPIPRAZOLE IN SUB-POPULATIONS OF BIPOLAR DISORDER PATIENTS WITH ACUTE MANIA: A POOLED ANALYSIS | Encore Presentation | |||
![]() | ELECTROCARDIOGRAPHIC EVALUATION OF INTRAMUSCULAR ZIPRASIDONE IN CHILDREN AND ADOLESCENTS | Original Research | |||
![]() | ELEVEN YEAR INTERIM RESULTS OF AN INTERNATIONAL OBSERVATIONAL STUDY OF PREGNANCY OUTCOMES FOLLOWING EXPOSURE TO LAMOTRIGINE | Encore Presentation | |||
![]() | Evaluation of an activation syndrome associated with the initiation of aripiprazole in children and adolescent inpatients admitted to a psychiatric unit at a university medical center | Work in Progress | |||
![]() | Evaluation of the Time Course of Reversal of Valproate Mediated Inhibition of Lamotrigine | Encore Presentation | |||
![]() | Evaluation of ziprasidone mesylate guidelines for use at the medical university of south carolina (MUSC) | Original Research | |||
![]() | Extended-Release Carbamazepine for Treatment of Manic and Mixed Symptoms | Encore Presentation | |||
![]() | GENETIC ANALYSIS OF THE RELATIONSHIP BETWEEN BRAIN-DERIVED NEUROTROPHIC FACTOR AND SCHIZOPHRENIA | Work in Progress | |||
![]() | GLYCEMIC CONTROL OF PSYCHIATRIC PATIENTS ON ATYPICAL ANTIPSYCHOTICS AND HYPOGLYCEMICS: A DRUG UTILIZATION EVALUATION | Work in Progress | |||
![]() | IMMEDIATE SWITCHING OF ANTIDEPRESSANT THERAPY:RESULTS FROM A CLINICAL TRIAL OF DULOXETINE | Encore Presentation | |||
![]() | Implementation of Safe Medication Practices Using Computer Technology in a Behavioral Health Acute Care Hospital | Best Practices | |||
![]() | Implementation of Safe Medication Practices Using Computer Technology in a Behavioral Health Acute Care Hospital | Best Practices | |||
![]() | Increased Risk of Mortality Associated with Psychotropic Drug Use in VA Patients Admitted for Pneumonia. | Original Research | |||
![]() | Increased Utilization of Ziprasidone Decreased Daily Antipsychotic Costs in an Inpatient Unit | Original Research | |||
![]() | Infection risk among patients receiving long-term clozapine treatment. | Work in Progress | |||
![]() | Insight into Medication Knowledge and Reasons for Nonadherence as Reported by Patients with Mental Illness | Original Research | |||
![]() | Introduction of an Opiate Review Committee into a Restricted Access Health Care System | Best Practices | |||
![]() | LONG-TERM EFFECTS OF ATOMOXETINE ON GROWTH IN CHILDREN WITH ADHD | Encore Presentation | |||
![]() | Long-Term Efficacy and Safety of Galantamine Extended Release for the Treatment of Mild to Moderate Alzheimer’s Disease | Original Research | |||
![]() | MEMANTINE DECREASES THE LEVELS OF ALZHEIMER β-AMYLOID PROTEINS IN RAT PRIMARY CORTICAL NEURONS AND HUMAN NEUROBLASTOMA CELLS | Encore Presentation | |||
![]() | METABOLIC MONITORING WITH ATYPICAL ANTIPSYCHOTICS: IMPACT OF PUBLISHED GUIDELINES | Work in Progress | |||
![]() | Off-label use of Selective Serotonin Reuptake Inhibitors in a Family Medicine Practice | Original Research | |||
![]() | Open-Label Trial of Escitalopram in the Treatment of PTSD | Original Research | |||
![]() | OVERALL TREATMENT EFFECTIVENESS AS MEASURED BY TIME CONTINUING ON ANTIPSYCHOTIC THERAPY | Encore Presentation | |||
![]() | OVERALL TREATMENT EFFECTIVENESS AS MEASURED BY TIME CONTINUING ON ANTIPSYCHOTIC THERAPY | Encore Presentation | |||
![]() | Pharmacoeconomics and Design of Optimal Dosage Regimens | Best Practices | |||
![]() | PRESCRIBING PATTERNS OF ATYPICAL ANTIPSYCHOTICS IN PATIENTS DISCHARGED FROM A UNIVERSITY BASED PSYCHIATRIC HOSPITAL | Work in Progress | |||
![]() | Prevention of Panic Disorder Relapse in Adult Outpatient Responders to Treatment with Venlafaxine XR | Encore Presentation | |||
![]() | QUALITY-OF-LIFE ASSESSMENT IN ATOMOXETINE-TREATED ADULT PATIENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | Encore Presentation | |||
![]() | Quetiapine for the Treatment of Agitation in Institutionalized Patients with Dementia: A Randomized, Double-Blind Trial | Encore Presentation | |||
![]() | Rehospitalization Rates during Conditional Release in Mentally Ill Forensic Commitments: A Retrospective Study | Work in Progress | |||
![]() | Relationship Between Sub-therapeutic Dosing of Atypical Antipsychotic Agents and Use of Adjunct Antidepressant and Antianxiety Agents | Original Research | |||
![]() | Retrospective Analysis of Extended-Release Divalproex for Schizophrenia and Mood Related Disorders in an Inpatient Mentally Ill Population | Original Research | |||
![]() | SAFETY AND EFFICACY OF MAS XR IN ADOLESCENTS WITH ADHD | Encore Presentation | |||
![]() | SAFETY AND EFFICACY OF MIXED AMPHETAMINE SALTS EXTENDED RELEASE IN CHILDREN AND ADOLESCENTS WITH OPPOSITIONAL DEFIANT DISORDER (ODD) | Encore Presentation | |||
![]() | Serotonin 5HT2A (-1438G/A and T102C) and G-protein beta subunit (GNB3 C825T) polymorphisms and SSRI-associated sexual dysfunction | Work in Progress | |||
![]() | Switch rate comparison among antidepressant agents | Work in Progress | |||
![]() | Switching form immediate-release to extended-release carbamazepine capsules: safety and tolerability in adolescents with epilepsy | Encore Presentation | |||
![]() | Switching Patients With Alzheimer’s Disease From Galantamine Immediate-Release to Extended-Release Formulation: A Pharmacokinetic Simulation | Original Research | |||
![]() | Symptom profiles of prepubertal children with a diagnosis of ADHD, bipolar disorder, or a depressive disorder | Original Research | |||
![]() | THE EFFECT OF PHARMACEUTICAL CARE INVOLVING REINFORCEMENT OF NON-PHARMACOLOGICAL TREATMENT ON ABSTINENCE IN BUPRENORPHINE TREATED PATIENTS | Work in Progress | |||
![]() | The Effect of Second Generation Antipsychotics on Weight Gain in Children and Adolescents | Work in Progress | |||
![]() | The Prevalence of Co-Morbid Physical Illness in State Hospital Inpatients with Schizophrenia | Original Research | |||
![]() | The use of the adverse event profile for evaluating tolerabilty of carbamazepine therapy given as immediate-release and extended-release formulations | Encore Presentation | |||
![]() | Tolerability of Escitalopram in the Treatment of Social Anxiety Disorder | Encore Presentation | |||
![]() | Treatment of Manic and Mixed Patients with Extended-Release Carbamazepine | Encore Presentation | |||
![]() | UPDATE OF MEMANTINE SAFETY IN SHORT- AND LONG-TERM TREATMENT OF DEMENTIA | Original Research | |||
![]() | Venlafaxine XR and Paroxetine in the Short-Term Treatment of Panic Disorder | Encore Presentation |